CIK: 1459154 - Address: C/o Coherus Biosciences, Inc., 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret115-2-4-92-24-3-7
S%wins808010080756780

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/5/24 19:03
2/1/24
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADM.d1001.67060150100D
6/19/20 16:33
6/17/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS-3,43017.150-200-1000I
3/5/20 16:31
3/3/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS-2,37520.120-118-37200I
12/9/16 16:05
12/7/16
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS.m-1,47527.5210-54-8579I831574-6-6-10-1-1-1-1-17
5/26/16 16:05
8/18/15
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS.a-21333.509-6-1632I-28-3832-17-212-608-156053
8/20/15 16:05
8/18/15
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS-21433.509-6-1632I11212-10-10-111-7-6-7-492
8/19/15 16:06
8/17/15
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS-27233.919-8-1638I142612-10-5-7-3-9-7-11-49-2
8/18/15 16:05
8/14/15
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagWahlstrom MatsCADS-3,99034.249-117-15647I253513-8-1-1-5-12-17-16-50-9

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact